Skip to content
Disclosery

EXANE DERIVATIVES: EHC position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on EHC, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 12,693 EHC shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 12,693 shares
    Change vs previous 13F -3,520 shares

    0.41% of the 13F portfolio, value $711,297.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 16,213 shares
    Change vs previous 13F -115 shares

    0.32% of the 13F portfolio, value $1,152,835.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 16,328 shares
    Change vs previous 13F +13,653 shares

    0.26% of the 13F portfolio, value $1,065,527.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 2,675 shares
    Change vs previous 13F -187 shares

    0.05% of the 13F portfolio, value $200,725.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 2,862 shares
    Change vs previous 13F +1,799 shares

    0.05% of the 13F portfolio, value $229,527.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 1,063 shares
    Change vs previous 13F -1,440 shares

    0.03% of the 13F portfolio, value $87,056.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 2,503 shares
    Change vs previous 13F +1,390 shares

    0.06% of the 13F portfolio, value $206,963.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 1,113 shares
    Change vs previous 13F not available

    0.02% of the 13F portfolio, value $72,319.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).